Glenmark Pharmaceuticals Limited Press Release Jul 02 2026

About this update from Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 02, 2026, titled "Glenmark Advances Multi-Country Phase 3 Clinical Trial of Trastuzumab rezetecan in Platinum-Resistant Ovarian Cancer". View Attachment

View stock analysis, news, and events for Glenmark Pharmaceuticals Limited